Journal of Hepatology
Volume 51, Issue 5 , Pages 881-889 , November 2009

Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy

  • Marie-Charlotte Domart

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • These authors contributed equally to this work.
    • ,
  • Davide Degli Esposti

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • Laboratoire de Biochimie et Biologie Cellulaire, Faculté de Pharmacie, Châtenay-Malabry Cedex, France
    • These authors contributed equally to this work.
    • ,
  • Mylène Sebagh

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service d’Anatomie Pathologique, Inserm U785, Université Paris-Sud 11, Institut André Lwoff, Villejuif Cedex, France
    • ,
  • Natalia Olaya

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • ,
  • Francis Harper

      Affiliations

    • Institut André Lwoff, UPR-1983, Laboratoire Réplication de l’ADN et Ultrastructure du Noyau, Villejuif, France
    • ,
  • Gérard Pierron

      Affiliations

    • Institut André Lwoff, UPR-1983, Laboratoire Réplication de l’ADN et Ultrastructure du Noyau, Villejuif, France
    • ,
  • Brigitte Franc

      Affiliations

    • AP-HP, Hôpital Ambroise Paré, Service d’Anatomie Pathologique, Boulogne-Billancourt, Université Versailles/St Quentin, PRES Universud-Paris, Versailles, France
    • ,
  • Kenneth K. Tanabe

      Affiliations

    • Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
    • ,
  • Brigitte Debuire

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • ,
  • Daniel Azoulay

      Affiliations

    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • AP-HP, Hôpital Paul Brousse, Centre Hépatobiliaire, Université Paris-Sud 11, Villejuif Cedex, France
    • ,
  • Catherine Brenner

      Affiliations

    • CNRS UMR 8159, Université Versailles/St. Quentin, PRES Universud-Paris, Versailles, France
    • ,
  • Antoinette Lemoine

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • Laboratoire de Biochimie et Biologie Cellulaire, Faculté de Pharmacie, Châtenay-Malabry Cedex, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 1 45593693; fax: +33 1 45593625.

Received 18 February 2009 ,Revised 26 May 2009 ,Accepted 17 June 2009.

References 

  1. Saltz L, Kelsen D. Adjuvant treatment of colorectal cancer. Annu Rev Med. 1997;48:191–202
  2. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274–286
  3. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1–7
  4. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983–4990
  5. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005;6:845–853
  6. El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology. 2007;45:855–863
  7. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292–298
  8. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia preconditioning: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136
  9. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843–850
  10. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology. 2003;125:1480–1491
  11. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125:1246–1257
  12. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg. 2003;20:383–396
  13. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia–reperfusion in the rat: role of nitric oxide and adenosine. Hepatology. 1997;4:934–937
  14. Selzner N, Selzner M, Jochum W, Clavien PA. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol. 2003;39:55–61
  15. Barrier A, Olaya N, Chiappini F, Roser F, Scatton O, Artus C, et al. Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia–reperfusion. FASEB J. 2005;19:1617–1626
  16. Li SQ, Liang LJ, Huang JF, Li Z. Ischemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis. World J Gastroenterol. 2004;10:2580–2584
  17. Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg. 2006;202:203–211
  18. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24:289–293
  19. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;6:239–257
  20. Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol. 1961;9:409–414
  21. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741–752
  22. Benzina S, Altmeyer A, Malek F, Dufour P, Denis JM, Gueulette J, et al. High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Lett. 2008;264:63–70
  23. von Bültzingslöwen I, Jontell M, Hurst P, Nannamark U, Kardos T. 5-Fluorouracil induces autophagic degeneration in rat oral keratinocytes. Oral Oncol. 2001;37:537–544
  24. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280–1288
  25. Yadav SS, Sindram D, Perry DK, Clavien PA. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology. 1999;30:1223–1231
  26. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155–162
  27. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med. 1996;2:80–86
  28. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S. Role of Bcl-2 family proteins in a non apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004;6:1221–1228
  29. Charlotte F, L’Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, et al. Immunohistochemical detection of Bcl-2 protein in normal and pathological human liver. Am J Pathol. 1994;144:460–465
  30. Kurosawa H, Que FG, Roberts LR, Fesmier PG, Gores GJ. Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol. 1997;272:G1587–G1593
  31. Haendeler J, Messmer UK, Brune B, Neugebauer E, Dimmeler S. Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock. 1996;6:405–409
  32. Belzacq AS, Vieira HL, Verrier F, Vandecasteele G, Cohen I, Prévost MC, et al. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res. 2003;63:541–546
  33. Chen ZX, Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ. 2007;14:1617–1627
  34. Yamabe K, Shimizu S, Kamiike W, Waguri S, Eguchi Y, Hasegawa J, et al. Prevention of hypoxic liver cell necrosis by in vivo human bcl-2 gene transfection. Biochem Biophys Res Commun. 1998;243:217–223
  35. Pattingre S, Bauvy C, Carpentier S, Levade T, Levine B, Codogno P. Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J Biol Chem. 2009;284:2719–2728
  36. Fazi B, Bursch W, Fimia GM, Nardacci R, Piacentini M, Di Sano F, et al. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy. 2008;4:435–441

☆ The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00519-4

doi: 10.1016/j.jhep.2009.06.028

Journal of Hepatology
Volume 51, Issue 5 , Pages 881-889 , November 2009

Article Tools

* Image Usage & Resolution